July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.
June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.
Rectal and throat tests matter too, and providers should be recommending them.
These two tests make it easier to diagnose sexually transmitted infections that often go untreated.
May 23, 2019: How CD4 variables over time affect anal cancer risk; when to consider anal pap smears for women; switching from E/C/F/TAF to ABC/3TC; new data on marijuana use among people with HIV.
A new CDC study suggests that many urgent care centers in the U.S. still need to be made aware of pre-exposure prophylaxis and how to provide it.
New Study Finds HPV Infection High -- and Vaccination Rates Low -- in Young Sexual Minority Men and Transgender Women
More awareness of human papillomavirus is needed for gay/bisexual men and transgender women of color -- and their health care providers, research suggests.
However, a number of leading clinicians argue that the results should not deter care providers from prescribing PrEP for patients who are most at risk for HIV.
The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.
Internalized HIV stigma, depression, and adherence in women; what “internalized HIV stigma” actually means; tenofovir-containing gel and genital herpes prevention; the neurocognitive effects of cerebrospinal HIV escape.